MedPath

Haloperidol

Haloperidol Tablets, USP

Approved
Approval ID

f20769bc-98a3-419a-ba36-2e9737050cd9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 16, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Haloperidol

PRODUCT DETAILS

NDC Product Code63629-9274
Application NumberANDA071173
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 2, 2019
Generic NameHaloperidol

INGREDIENTS (5)

HALOPERIDOLActive
Quantity: 5 mg in 1 1
Code: J6292F8L3D
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C BLUE NO. 1 ALUMINUM LAKEInactive
Code: J9EQA3S2JM
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Haloperidol - FDA Drug Approval Details